-

CRO Activity and Intel Report, Q1 2025 - CRO and Sponsor Activity, Clinical Trial Trends, and Geographical Performance Across Various Therapeutic Areas - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Q1 2025 CRO Activity and Intel Report" report has been added to ResearchAndMarkets.com's offering.

This report provides an in-depth analysis of the contract research organization (CRO) industry for Q1 2025, segmented by geography, therapeutic area, and phase of development. It delivers insights into CRO and sponsor activity, clinical trial trends, and geographical performance across various therapeutic areas.

Reasons to Buy

  • This report will enable the user to answer the following questions:
  • What are the trends by region, therapy area, sites by CROs for the past quarter?
  • Who was the most active CRO in the past quarter?
  • Who were the most active sponsors by market cap in the past quarter?
  • What was the most widely studied therapy area in the past quarter vs. the previous year's quarter?
  • By region, who had the most clinical trials initiated in the past quarter?
  • By region, what were the past quarter's CRO invitations and appointments?

Key Topics Covered:

Global

  • CRO and sponsor activity in Q1 2025
  • Most-used CROs
  • Most active large- and mega-cap sponsors
  • Most active mid-cap sponsors
  • Most active small-cap sponsors
  • Clinical trials in oncology and CNS
  • Therapeutic area breakdown of clinical trials initiated in Q1 2025 vs. Q1 2024
  • Trials initiated in the 10 most active oncology indications in Q1 2025 vs. Q1 2024
  • Trials initiated in the 10 most active CNS indications in Q1 2025 vs. Q1 2024
  • Top 10 CROs by number of sites in Q1 2025

North America

  • Clinical trial activity in North America in Q1 2025
  • Most active North American regions in Q1 2025 vs. Q1 2024
  • Phase breakdown of trials initiated in North America in Q1 2025 vs. Q1 2024
  • Therapeutic area breakdown of clinical trials initiated in North America in Q1 2025 vs. Q1 2024
  • Top 10 trial sites by trials initiated in North America in Q1 2025
  • Insights: CRO invites for sponsors based in North America
  • Insights: CRO appointments for sponsors based in North America

Europe

  • Clinical trial activity in Europe in Q1 2025
  • Most active European regions in Q1 2025 vs. Q1 2024
  • Phase breakdown of trials initiated in Europe in Q1 2025 vs. Q1 2024
  • Therapeutic area breakdown of clinical trials initiated in Europe in Q1 2025 vs. Q1 2024
  • Top 10 trial sites by trials initiated in Europe in Q1 2025
  • Insights: CRO invites for sponsors based in Europe
  • Insights: CRO appointments for sponsors based in Europe

Rest of the world

  • Clinical trial activity in ROW in Q1 2025
  • Most active regions in ROW in Q1 2025 vs. Q1 2024
  • Phase breakdown of trials initiated in ROW in Q1 2025 vs. Q1 2024
  • Therapeutic area breakdown of clinical trials initiated in ROW in Q1 2025 vs. Q1 2024
  • Top 10 trial sites by trials initiated in ROW in Q1 2025

A selection of companies mentioned in this report includes, but is not limited to:

  • ICON
  • Astrazeneca
  • Akesobio
  • CSPPC Pharmaceutical
  • ImmunityBio
  • Boryung

For more information about this report visit https://www.researchandmarkets.com/r/j9ak83

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Industry:

Research and Markets

Release Versions
English

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Southeast Asia iGaming Market Intelligence Report 2025-2034 Featuring In-Depth Profiles of 15 Industry Players Including 888Casino, Bet365, Habanero Systems - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Southeast Asia iGaming Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" has been added to ResearchAndMarkets.com's offering. The Southeast Asia iGaming Market was valued at USD 1.27 billion in 2024 and is estimated to grow at a CAGR of 21% to reach USD 8.30 billion by 2034. Market expansion remains closely tied to the region's diverse and highly fragmented regulatory landscape, where each country applies its own framework ranging...

Military Trucks Market Forecast and Technology Research Report 2025-2033: Economic Growth through Military Truck Procurement and Global Supply Chain Integration - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Military Trucks - Market and Technology Forecast to 2033" report has been added to ResearchAndMarkets.com's offering. Military trucks are the "workhorses" of modern armed forces providing mobility from the strategic all the way down to the tactical level. The breadth of logistical and mobility support they offer is extensive, ranging from transportation of troops and equipment to being the platform of weapon systems, such as artillery howitzers and missiles or air...

Latin America Digital Commerce & Payments in the Age of AI, 2025-2027 Market Research Report - Focus on Argentina, Brazil, Chile, Colombia, Guatemala, Mexico, and Peru - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Latin America Digital Commerce & Payments in the Age of AI, 2026" report has been added to ResearchAndMarkets.com's offering. This report analyzes how digital commerce, the evolving payments landscape, and artificial intelligence are reshaping retail and financial services across Latin America, providing in-depth coverage of market development, transaction infrastructure, consumer behavior, and enterprise transformation across Brazil, Mexico, Argentina, Colombi...
Back to Newsroom